In this feasibility study of a multiple cancer screening program in Hong Kong we observed that if an individual has accepted colorectal cancer screening with FIT, the chance of him accepting an additional screening test for prostate cancer (using PSA) or her accepting an additional screening test for breast cancer (undergoing MMG) is very high (over 99%). This evidence concerns the gene KLK3 and colorectal cancer.